Acute Gastroenteritis: Its Causes, Maintenance, And Treatment
Abstract
Diarrhoea is a huge public health issue, even in the wealthy world. For patients with severe diarrhoea, it might be difficult to determine which pathogens should be investigated before beginning antimicrobial therapy. Gastroenteritis is an infectious ailment that produces nausea, vomiting, diarrhoea, and abdominal pain. In the United States, the CDC estimates that acute gastroenteritis affects 350 million people each year, with food-borne germs accounting for 48 million of those cases. Both community-acquired diarrhoea and traveller's diarrhoea are addressed in terms of epidemiology when discussing acute gastroenteritis therapy and management. Traveller’s diarrhoea affects more than half of those who travel from rich countries to developing countries. In the United States, Clostridium difficile is becoming more common in individuals of all ages. Acute hydration or sufficient fluid intake is the basic treatment for acute gastroenteritis. Since acute gastroenteritis usually resolves on its own, antibiotics are rarely needed in most cases. Antibiotic therapy may be necessary for some situations, such as those with fever and bloody diarrhoea or those with an immunocompromised state, such as those with febrile diarrhoea. Assessing and treating infants and children with acute gastroenteritis should be based on scientific data, and that is what this study aims to do. Many people die as a result of dehydration, electrolyte imbalance, and metabolic acidosis. Dehydration and its…
Read the paper
Related studies
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Treatment of norovirus infections: moving antivirals from the bench to the bedside
- Abstracts of the 2012 International Congress of the European Association of Poisons Centres and Clinical Toxicologists, 25 May–1 June 2012, London, UK
- Global Research Trends in Irritable Bowel Syndrome: A Bibliometric and Visualized Study
- Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.